Screening for Prostate Cancer in Military Populations

Author: Moul, Judd W.

Source: Military Medicine, Volume 170, Number 11, November 2005 , pp. 905-914(10)

Publisher: AMSUS - Association of Military Surgeons of the U.S.

Buy & download fulltext article:

OR

Price: $20.00 plus tax (Refund Policy)

Abstract:

With the widespread use of the prostate-specific antigen (PSA) test, smaller cancers are being detected among younger men and 5-year, cancer-specific, survival rates are on the rise. Although this lead-time effect may not translate into long-term improvement, these changes are a necessary prerequisite to effective screening. For high-risk patients, i.e., men with a family history of the disease and African American men, a strategy consisting of annual PSA blood testing and digital rectal examination for men ≥40 years of age appears prudent. Many low/average-risk men of age 40 to 49 also request testing, and it is reasonable to offer testing and risk assessment to them. The exact screening threshold for total PSA levels for these men is not known, but 95% have PSA levels of ≤1.5 to 2.5 ng/mL. PSA velocity (<20% per year), percentage of free PSA (>18–25%), and complexed PSA levels may be used to help determine risk. More study of young men is needed.

Document Type: Research article

Affiliations: 1: Urology Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC 20307-5001.

Publication date: 2005-11-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page